EBIT at other companies
Other financials
Where this comes from
Calculated from PTC Therapeutics’s reported figures.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's EBIT?
- PTC Therapeutics (PTCT) reported EBIT of $44.96M in Q1 2026.
- How has PTC Therapeutics's EBIT changed year-over-year?
- PTC Therapeutics's EBIT decreased by 95.4% year-over-year, from $970.23M to $44.96M.
- What is the long-term trend for PTC Therapeutics's EBIT?
- Over 4 years (2021 to 2025), PTC Therapeutics's EBIT has grown at a 25.8% compound annual growth rate (CAGR), from -$374.45M to $938.28M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.